Coastal Bridge Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Coastal Bridge Advisors's REGN Position: Q2 2026 in Review
Coastal Bridge Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 6.1% in Q2 2026, buying an estimated $63.3K and bringing the position to 1,614 shares worth $1.01M. The position accounts for 0.06% of the portfolio, ranked #228.
Coastal Bridge Advisors first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.18M in Q1 2026. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Coastal Bridge Advisors held 1,614 shares of Regeneron Pharmaceuticals worth $1.01M as of Q2 2026.
- Coastal Bridge Advisors bought 93 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $63.3K.
- Regeneron Pharmaceuticals made up 0.06% of Coastal Bridge Advisors's portfolio in Q2 2026, its #228 holding.
- Coastal Bridge Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Coastal Bridge Advisors's Regeneron Pharmaceuticals position peaked at $1.18M in Q1 2026.
- 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.